Truist Securities Maintains Hold on ABM Indus, Raises Price Target to $49
Truist Securities analyst Jasper Bibb maintains ABM Indus (NYSE:ABM) with a Hold and raises the price target from $45 to $49.
Stocks · News reference
United Natural Foods, ABM Industries and 3 Stocks to Watch Heading Into Tuesday
Stocks in focus: UNFI and ABM earnings, Novartis trial miss, Co-Diagnostics CFO change, and Casey’s earnings expected.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Apple To $370? Here Are 10 Top Analyst Forecasts For Thursday
Analysts cut targets for AAPL, CHWY, COO, TYRA and CNM; raised DLR, DPZ, SIG, while ratings stayed unchanged.
UBS Maintains Neutral on ABM Indus, Raises Price Target to $51.5
ABM Analysts Boost Their Forecasts After Upbeat Q3 Earnings
ABM beats Q3 estimates, posts record revenue, narrows FY26 EPS outlook; analysts raise price targets to $58 and $53.
S&P 500 Stock Casey's Dropped 30% in Its Biggest Pullback Since the Great Recession -- Here's Why I'm Buying More
Casey's General Stores stock has fallen 30% from its June all-time high, driven by disappointing earnings guidance, slowing inside sales growth, and concerns about consumer financial stress. However, the author views this as a buying opportunity, as the company's valuation has normalized from 50x to 31x earnings. With a strong acquisition strategy, 25 years of same-store sales growth, and plans to add 400+ stores by 2029, Casey's remains well-positioned for long-term growth despite near-term headwinds.
RBC Capital Upgrades Casey's General Stores to Outperform, Lowers Price Target to $825